The results revealed that for both right- and left-sided cancers in the TCGA cohort, a high MRE11 expression is associated with a trend towards worse survival, but contrasting data from rectal cancers showed that low MRE11 expression confers worse outcomes. This evidence concerns the gene MRE11 and rectal cancer.